US Secures 300 Million Doses of Potential AstraZeneca COVID-19 Vaccine US Secures 300 Million Doses of Potential AstraZeneca COVID-19 Vaccine

The United States has secured almost a third of the first one billion doses planned for AstraZeneca ' s experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news